Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

298 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis

NCT03573323

Conditions
Plaque Psoriasis
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alliance Dermatology and Mohs Center Phoenix, Arizona, United States
  • Perseverance Research Center Scottsdale, Arizona, United States
View all 124 locations
View Trial Details
Completed

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis

NCT02899988

Conditions
Plaque Psoriasis
Locations
  • Renstar Medical Research Ocala, Florida, United States
  • Forward Clinical Trials, Inc Tampa, Florida, United States
  • The Indiana Clinical Trials Center, PC Plainfield, Indiana, United States
  • The South Bend Clinic South Bend, Indiana, United States
View all 40 locations
View Trial Details
Completed

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis

NCT02561806

Conditions
Plaque Psoriasis
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wein, Austria
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ghent, Belgium
  • For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Calgary, Canada
View all 48 locations
View Trial Details
Completed

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

NCT02513550

Conditions
Plaque Psoriasis
Locations
  • Total Skin and Beauty Dermatology Center PC Birmingham, Alabama, United States
  • Anaheim Clinical Trials, LLC Anaheim, California, United States
  • David Stoll, M.D. Beverly Hills, California, United States
  • Dermatology Research Associates Los Angeles, California, United States
View all 125 locations
View Trial Details
Completed

Comparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque Psoriasis

NCT02489227

Conditions
Plaque Psoriasis
Locations
  • Sadra Sasha Jazayeri, MD Phoenix, Arizona, United States
  • Encino Research Center Encino, California, United States
  • Center for Dermatology and Laser Surgery Sacramento, California, United States
  • Kenneth M Stein, MD Santa Rosa, California, United States
View all 99 locations
View Trial Details

Related conditions